Healthcare · Vaccine antigens production
Colombia produces no vaccine antigens of its own (8 million doses in 2026), ranking 32nd globally. The country relies entirely on imports of finished vaccines and bulk antigens, primarily from India, China, and Europe. The absence of domestic production stems from high capital costs for biotech facilities and lengthy certification processes. Instead, Colombia focuses on expanding vaccination programs and cold-chain logistics.
Data for 2026 · unit: million doses
Position
#32 / 197
Colombia world ranking
Country position on the scale from last to first place for this indicator.
CO
#32
#197#1
Trend
Change over time
Change in indicator over the available period.
1
1950
2
1990
5
2000
2
2010
5
2020
8
2025
8
2026
Values — million doses
Comparison
Top countries by Vaccine antigens production
Where Colombia stands in the world ranking.
1
CNChina
5 K
2
USUSA
500
3
BRBrazil
400
4
FRFrance
160
5
INIndia
100
5
RURussia
100
7
CACanada
60
8
AUAustralia
50
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Vaccine antigens production in Colombia — how much?
Based on 2026 data — 8 million doses. This is rank #32 out of 197 countries.
What is Colombia's rank by Vaccine antigens production?
Colombia ranks #32 out of 197 countries in the world ranking by «Vaccine antigens production».
How has Vaccine antigens production changed in Colombia?
Over the available period the indicator changed from 1 to 8 million doses.